Search Options Stock News and Analysis from Schaeffer's

Iovance Stock Eyes Best Day Since 2020 After FDA Nod

https://www.schaeffersresearch.com/content/news/2024/02/20/iovance-stock-eyes-best-day-since-2020-after-fda-nod

2/20/2024 10:26 AM

Iovance Biotherapeutics Inc (NASDAQ:IOVA) stock is up 39.5% at $12.76 at last check, after the company received accelerated approval from the Food and Drug Administration (FDA) for its cell therapy f...

Wall Street Wraps Winning Year With Big Plans For 2024

https://www.schaeffersresearch.com/content/news/2023/12/29/wall-street-wraps-winning-year-with-big-plans-for-2024

12/29/2023 2:59 PM

Despite the low-volume, post-Christmas trading environment, where headlines are few and far between, there was plenty to unpack for the final week of 2023. The Dow Jones Industrial Average (DJI) co...

Options Traders Target Plunging Biotech Stock

https://www.schaeffersresearch.com/content/news/2023/12/27/options-traders-target-plunging-biotech-stock

12/27/2023 10:37 AM

Iovance Biotherapeutics Inc (NASDAQ:IOVA) was last seen 17.8% lower to trade at $7.31, one of the worst stock's on the Nasdaq today. The bear gap comes after the U.S. Food and Drug Administration (F...

Biotech Stock Pops on Reaction to Experimental Therapy

https://www.schaeffersresearch.com/content/news/2023/07/10/biotech-stock-pops-on-reaction-to-experimental-therapy

7/10/2023 10:22 AM

Iovance Biotherapeutics Inc (NASDAQ:IOVA) was last seen up 2.4% at $7.42, after the U.S. Food and Drug Administration (FDA) said a late-stage study of its experimental lung cancer therapy, LN-145 T...

Biotech Stock Surges on FDA Update

https://www.schaeffersresearch.com/content/news/2023/05/30/biotech-stock-surges-on-fda-update

5/30/2023 11:24 AM

The shares of Iovance Biotherapeutics Inc (NASDAQ:IOVA) were last seen up 10.7% to trade at $8.36, after the U.S. Food and Drug Administration (FDA) reportedly accepted the company's license applic...

PEOPLE ALSO SEARCH FOR